Evonik Declines $11.7B BASF Bid
Evonik rejected the offer from BASF, which proposed a $11.7 billion acquisition, considering the price too low to warrant negotiations or due diligence. The offer was non-binding and represents the latest development in BASF's efforts to acquire Evonik, amid challenges faced by the German chemical sector due to rising costs and global competition.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)